Associated Papers
Comprehensive analysis of the functional impact of single nucleotide variants of human CHEK2.
McCarthy-Leo CE et al.
Plos Genetics, 2024
Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
Dorling L et al.
Genome Medicine, 2022
Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland.
Złowocka-Perłowska E et al.
Hereditary Cancer in Clinical Practice, 2022
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
Hoyer J et al.
Bmc Cancer, 2018
The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.
Bernstein-Molho R et al.
Breast Cancer Research and Treatment, 2018
Dupuytren's disease and the risk of malignant neoplasms.
Zyluk A et al.
Hereditary Cancer in Clinical Practice, 2014
An inherited NBN mutation is associated with poor prognosis prostate cancer.
Cybulski C et al.
British Journal of Cancer, 2013
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
Karami F et al.
Biomed Research International, 2013
BRCA1 mutations and colorectal cancer in Poland.
Suchy J et al.
Familial Cancer, 2010
The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
Uglanitsa N et al.
Clinical Genetics, 2010
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations.
Cybulski C et al.
Journal of Medical Genetics, 2009
Analysis of BRCA1/BRCA2 genes' contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women.
Distelman-Menachem T et al.
Familial Cancer, 2009
Germline CHEK2 mutations in Jewish Ashkenazi women at high risk for breast cancer.
Laitman Y et al.
The Israel Medical Association Journal : Imaj, 2007
Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin.
Cybulski C
Hereditary Cancer in Clinical Practice, 2007
Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Nanda R et al.
Jama, 2005
Breast cancer predisposing alleles in Poland.
Górski B et al.
Breast Cancer Research and Treatment, 2005